Zobrazeno 1 - 10
of 16
pro vyhledávání: '"John Raemaekers"'
Autor:
Wendy B. C. Stevens, G. Tjitske Los-de Vries, Carole Langois-Jacques, Andrew J. Clear, Phylicia Stathi, Birgitta Sander, Andreas Rosenwald, Maria Calaminici, Eva Hoster, Wolfgang Hiddemann, Philippe Gaulard, Gilles Salles, Wolfram Klapper, Luc Xerri, Catherine Burton, Reuben M. Tooze, Alexandra G. Smith, Christian Buske, David W. Scott, Yasodha Natkunam, Ranjana Advani, Laurie H. Sehn, John Raemaekers, John Gribben, Sandra Lockmer, Eva Kimby, Marie José Kersten, Delphine Maucort-Boulch, Bauke Ylstra, Erik van Dijk, Daphne de Jong
Publikováno v:
HemaSphere, Vol 7, Iss 4, p e863 (2023)
Externí odkaz:
https://doaj.org/article/ebf13b82395e42caa214d0852fc3edd2
Autor:
Cédric Rossi, Marc André, Jehan Dupuis, Franck Morschhauser, Bertrand Joly, Julien Lazarovici, Hervé Ghesquières, Aspasia Stamatoullas, Emmanuelle Nicolas-Virelizier, Pierre Feugier, Anne-Claire Gac, Hannah Moatti, Luc-Matthieu Fornecker, Bénédicte Deau, Clémentine Joubert, Catherine Fortpied, John Raemaekers, Massimo Federico, Salim Kanoun, Michel Meignan, Alexandra Traverse-Glehen, Anne-Ségolène Cottereau, René-Olivier Casasnova
Publikováno v:
Haematologica, Vol 107, Iss 12 (2022)
Stage IIB Hodgkin lymphoma (HL) patients, with a mediastinum-to-thorax (M/T) ratio of ≥0.33 or extranodal localization have a poor prognosis and are treated either as limited or advanced stage. We compared these two approaches in patients included
Externí odkaz:
https://doaj.org/article/3bfa108c1d994483b55ceb83af3e2524
Autor:
Frans X. Plooij, John Raemaekers
Publikováno v:
Clinical Case Reports, Vol 8, Iss 12, Pp 2947-2953 (2020)
Abstract If the lymphocyte count is still low enough, the first part of the wait‐and‐see approach for asymptomatic Rai stage 0 classical B‐CLL can be used to find out if the lymphocyte counts follow an exponential growth curve. If they do, the
Externí odkaz:
https://doaj.org/article/d95bede88ce5495c918c29a60e0e768c
Autor:
Berbel Ykema, Lisanne Rigter, Manon Spaander, Leon Moons, Tanya Bisseling, Berthe Aleman, Jan Paul de Boer, Pieternella Lugtenburg, Cecile Janus, Eefke Petersen, Judith Roesink, John Raemaekers, Richard van der Maazen, Iris Lansdorp-Vogelaar, Andrea Gini, Wieke Verbeek, Margriet Lemmens, Gerrit Meijer, Flora van Leeuwen, Petur Snaebjornsson, Beatriz Carvalho, Monique van Leerdam
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 1, p 190 (2020)
Background: Hodgkin lymphoma (HL) survivors have an increased colorectal cancer (CRC) risk. Diagnostic accuracy of quantitative fecal immunochemical testing (FIT, OC Sensor) and/or a multi-target stool DNA test (mt-sDNA, Cologuard®) for advanced neo
Externí odkaz:
https://doaj.org/article/98808add1aa2417caa689c2d3266a555
Autor:
Wendy B.C. Stevens, Matias Mendeville, Robert Redd, Andrew J. Clear, Reno Bladergroen, Maria Calaminici, Andreas Rosenwald, Eva Hoster, Wolfgang Hiddemann, Philippe Gaulard, Luc Xerri, Gilles Salles, Wolfram Klapper, Michael Pfreundschuh, Andrew Jack, Randy D. Gascoyne, Yasodha Natkunam, Ranjana Advani, Eva Kimby, Birgitta Sander, Laurie H. Sehn, Anton Hagenbeek, John Raemaekers, John Gribben, Marie José Kersten, Bauke Ylstra, Edie Weller, Daphne de Jong
Publikováno v:
Haematologica, Vol 102, Iss 8 (2017)
In follicular lymphoma, studies addressing the prognostic value of microenvironment-related immunohistochemical markers and tumor cell-related genetic markers have yielded conflicting results, precluding implementation in practice. Therefore, the Lun
Externí odkaz:
https://doaj.org/article/b6733729e0b74565b0f6b902d4cf130a
Autor:
Birgitta Sander, Daphne de Jong, Andreas Rosenwald, Wanling Xie, Olga Balagué, Maria Calaminici, Joaquim Carreras, Philippe Gaulard, John Gribben, Anton Hagenbeek, Marie José Kersten, Thierry Jo Molina, Abigail Lee, Santiago Montes-Moreno, German Ott, John Raemaekers, Gilles Salles, Laurie Sehn, Christoph Thorns, Björn E. Wahlin, Randy D. Gascoyne, Edie Weller
Publikováno v:
Haematologica, Vol 99, Iss 4 (2014)
The cellular microenvironment in follicular lymphoma is of biological and clinical importance. Studies on the clinical significance of non-malignant cell populations have generated conflicting results, which may partly be influenced by poor reproduci
Externí odkaz:
https://doaj.org/article/e70d25e1923c49058df4955645e5d83e
Autor:
Daphne de Jong, Ad Koster, Anton Hagenbeek, John Raemaekers, Dennis Veldhuizen, Sabien Heisterkamp, Jan Paul de Boer, Martine van Glabbeke
Publikováno v:
Haematologica, Vol 94, Iss 1 (2009)
Background The clinical behavior of follicular lymphoma is largely determined by properties of the non-malignant tumor microenvironment. The precise nature of the cell populations is still unclear and published data on their prognostic significance a
Externí odkaz:
https://doaj.org/article/028fbf13167b4e67b3fde2c4744ba9e2
Autor:
G. Tjitske Los-de Vries, Wendy B. C. Stevens, Erik van Dijk, Carole Langois-Jacques, Andrew J. Clear, Phylicia Stathi, Margaretha G. M. Roemer, Matias Mendeville, Nathalie J. Hijmering, Birgitta Sander, Andreas Rosenwald, Maria Calaminici, Eva Hoster, Wolfgang Hiddemann, Philippe Gaulard, Gilles Salles, Heike Horn, Wolfram Klapper, Luc Xerri, Catherine Burton, Reuben M. Tooze, Alexandra G. Smith, Christian Buske, David W. Scott, Yasodha Natkunam, Ranjana Advani, Laurie H. Sehn, John Raemaekers, John Gribben, Eva Kimby, Marie José Kersten, Delphine Maucort-Boulch, Bauke Ylstra, Daphne de Jong
Publikováno v:
Blood Advances, 6, 5482-5493
Blood Advances, 6, 18, pp. 5482-5493
Blood, 6(18), 5482-5493. American Society of Hematology
Blood advances, 6(18), 5482-5493. American Society of Hematology
Los-de Vries, G T, Stevens, W B C, van Dijk, E, Langois-Jacques, C, Clear, A J, Stathi, P, Roemer, M G M, Mendeville, M, Hijmering, N J, Sander, B, Rosenwald, A, Calaminici, M, Hoster, E, Hiddemann, W, Gaulard, P, Salles, G, Horn, H, Klapper, W, Xerri, L, Burton, C, Tooze, R M, Smith, A G, Buske, C, Scott, D W, Natkunam, Y, Advani, R, Sehn, L H, Raemaekers, J, Gribben, J, Kimby, E, Kersten, M J, Maucort-Boulch, D, Ylstra, B & de Jong, D 2022, ' Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV ', Blood, vol. 6, no. 18, pp. 5482-5493 . https://doi.org/10.1182/bloodadvances.2022008355
Blood Advances, 6, 18, pp. 5482-5493
Blood, 6(18), 5482-5493. American Society of Hematology
Blood advances, 6(18), 5482-5493. American Society of Hematology
Los-de Vries, G T, Stevens, W B C, van Dijk, E, Langois-Jacques, C, Clear, A J, Stathi, P, Roemer, M G M, Mendeville, M, Hijmering, N J, Sander, B, Rosenwald, A, Calaminici, M, Hoster, E, Hiddemann, W, Gaulard, P, Salles, G, Horn, H, Klapper, W, Xerri, L, Burton, C, Tooze, R M, Smith, A G, Buske, C, Scott, D W, Natkunam, Y, Advani, R, Sehn, L H, Raemaekers, J, Gribben, J, Kimby, E, Kersten, M J, Maucort-Boulch, D, Ylstra, B & de Jong, D 2022, ' Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV ', Blood, vol. 6, no. 18, pp. 5482-5493 . https://doi.org/10.1182/bloodadvances.2022008355
Contains fulltext : 282509.pdf (Publisher’s version ) (Open Access) Although the genomic and immune microenvironmental landscape of follicular lymphoma (FL) has been extensively investigated, little is known about the potential biological differenc
Autor:
John Raemaekers, Frans X Plooij
Publikováno v:
Clinical Case Reports
Clinical Case Reports, Vol 8, Iss 12, Pp 2947-2953 (2020)
Clinical Case Reports, Vol 8, Iss 12, Pp 2947-2953 (2020)
If the lymphocyte count is still low enough, the first part of the wait‐and‐see approach for asymptomatic Rai stage 0 classical B‐CLL can be used to find out if the lymphocyte counts follow an exponential growth curve. If they do, the whole foo
Autor:
Andreas, Rosenwald, Susanne, Bens, Ranjana, Advani, Sharon, Barrans, Christiane, Copie-Bergman, Mad-Helenie, Elsensohn, Yaso, Natkunam, Maria, Calaminici, Birgitta, Sander, Maryse, Baia, Alexandra, Smith, Daniel, Painter, Luu, Pham, Shuchun, Zhao, Marita, Ziepert, Ekaterina S, Jordanova, Thierry J, Molina, Marie José, Kersten, Eva, Kimby, Wolfram, Klapper, John, Raemaekers, Norbert, Schmitz, Fabrice, Jardin, Wendy B C, Stevens, Eva, Hoster, Anton, Hagenbeek, John G, Gribben, Reiner, Siebert, Randy D, Gascoyne, David W, Scott, Philippe, Gaulard, Gilles, Salles, Catherine, Burton, Daphne, de Jong, Laurie H, Sehn, Delphine, Maucort-Boulch
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37(35)
The study cohort included patients with histologically confirmed DLBCL morphology derived from large prospective trials and patient registries in Europe and North America who were uniformly treated with rituximab plus cyclophosphamide, doxorubicin, v